New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- Indy woman diagnosed with breast cancer in her 30’son October 15, 2019 at 6:47 pm
It has been 1 year since Ivy found out she has cancer. She tells FOX59’s Beairshelle Edmé that diagnosis, no matter what, is shocking, but especially when you’re in your 30s. Ivy is a newlywed chasing ...
- Breast cancer diagnosis rare but potentially very serious for menon October 15, 2019 at 6:36 pm
(NBC News) Breast cancer is a rare but potentially deadly diagnosis in men. Last month Minnesota resident Randy Klauk became one of the estimated 2,500 men who will be diagnosed this year in the ...
- Experts unpack all the difficult decisions breast cancer survivors must make when getting reconstructive surgeryon October 15, 2019 at 6:08 pm
I’ve lost a lot of women in my family to breast cancer—and if you’re dealing with an actual cancer diagnosis, you’re fighting for your life. It’s a deeply emotional process.” Breast cancer support ...
- After cancer diagnosis, nurse knows what it's like to be a patienton October 15, 2019 at 12:59 pm
After cancer diagnosis, nurse knows what it's like to be a patient Melissa Gushard is still thankful for her fellow nurses at OhioHealth Mansfield Hospital for helping her get through. Check out this ...
- Mansfield nurse learns to be a patient after breast cancer diagnosison October 15, 2019 at 12:52 pm
She said one of every eight women will have breast cancer at some point in their lives. "Once they have their surgery and start their chemo, I touch base with them throughout the process," Frederick ...
- ‘Vanderpump Rules’ cast raises funds for makeup artist Jared Lipscomb after cancer diagnosison October 15, 2019 at 12:48 pm
Cancer was the last thing on my mind.” After losing 30 pounds in the span of a month, Lipscomb went to the UCLA emergency room, where he received his diagnosis. He immediately had to cancel a booked ...
- The One Thing Sheryl Crow Wishes She'd Known Before Her Breast Cancer Diagnosison October 15, 2019 at 12:29 pm
Sheryl Crow was diagnosed with stage one breast cancer in February 2006, by way of a routine mammogram. At just 44 years old, she eventually had a lumpectomy (or the removal of cancerous tissue) in ...
- Global Pancreatic Cancer Therapeutics Diagnostics Market Growth, Trends and Forecast 2016-2022on October 15, 2019 at 5:02 am
Thus, it forms the largest market for the pancreatic cancer therapeutics and diagnostics. Following are the different driving and restraining factors for the global pancreatic cancer therapeutics and ...
- Global Ovarian Cancer Diagnostics and Therapeutics Market Growth, Trends, and Forecast 2016-2022on October 15, 2019 at 5:02 am
Hence, there is an increasing need to develop new medicines and therapies for its treatment along with the invention of new methods for the timely or early diagnosis of this cancer. Thus, the global ...
via Bing News